It Is What the Surgeon Does Not See That Kills the Patient

被引:1
作者
Sugarbaker, Paul H. [1 ]
机构
[1] Washington Canc Inst, Program Peritoneal Surface Malignancy, Washington, DC 20007 USA
关键词
colon cancer; CT; CEA; CA19-9; CA-125; colonoscopy; neoadjuvant chemotherapy; cytoreductive surgery; peritonectomy; METASTASES; FEATURES; CANCER; CT;
D O I
10.3390/jcm13082238
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with colon cancer may present at multiple different stages of the disease process. Many patients can be cured of colon cancer as a result of a simple surgical procedure usually performed by minimally invasive techniques. However, there are a variable number of patients, estimated at approximately 10%, who have a more advanced disease. If these patients are treated by the current conventional standard of care, the likelihood for treatment failure is extremely high. Methods: These are not patients with known disseminated disease but patients who are at high risk of recurrent disease unless special treatments are initiated preoperatively and intraoperatively. The identification of these patients is by (1) a high-quality CT scan, (2) tumor markers found preoperatively, (3) colonoscopic findings, and (4) symptoms. Results: Patients identified as being at high risk require special preoperative treatments which include neoadjuvant chemotherapy. Intraoperative chemotherapy with HIPEC should occur as part of the treatment if peritoneal metastases are documented by biopsy. In the operating room, a thorough exploration of all possible occult peritoneal spaces for metastatic disease needs to be performed. A modified cytoreductive surgical procedure along with a colon resection is performed in order to minimize sites of occult peritoneal metastases. This includes the greater omentum, ovaries, and tubes in postmenopausal women. Peritonectomy is used to create a shroud around the tumor so that all peritoneum that has been in direct contact with the tumor surface is resected and is used as a barrier against tumor cell dissemination in the process of colon cancer resection. If peritoneal metastases are visualized at any site, HIPEC should be included as part of the treatment package. Conclusions: I am convinced that patients at high risk of recurrence will have an improved outcome with proper preoperative evaluation, preoperative neoadjuvant chemotherapy, and a revised intraoperative management strategy.
引用
收藏
页数:10
相关论文
共 21 条
  • [1] Effect of High-Grade Disease on Outcomes of Surgically Treated Colon Cancer
    Amri, Ramzi
    Bordeianou, Liliana G.
    Berger, David L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1157 - 1163
  • [2] Multivisceral resection of advanced colon and rectal cancer: a prospective multicenter observational study with propensity score analysis of the morbidity, mortality, and survival
    Arndt, Michael
    Lippert, Hans
    Croner, Roland S.
    Meyer, Frank
    Otto, Ronny
    Ridwelski, Karsten
    [J]. INNOVATIVE SURGICAL SCIENCES, 2023, 8 (02): : 61 - 72
  • [3] Leveraging a nationwide infection surveillance program to implement a colorectal surgical site infection reduction bundle: a pragmatic, prospective, and multicenter cohort study
    Badia, Josep
    Arroyo-Garcia, Nares
    Vazquez, Ana
    Almendral, Alexander
    Gomila-Grange, Aina
    Fraccalvieri, Domenico
    Pares, David
    Abad-Torrent, Ana
    Pascual, Marta
    Solis-Pena, Alejandro
    Puig-Asensio, Mireia
    Pera, Miguel
    Gudiol, Francesc
    Limon, Enric
    Pujol, Miquel
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 737 - 751
  • [4] Brown G., 2020, Pictorial Essays on Peritoneal Metastases Imaging: CT, MRI and PET-CT, P57
  • [5] An Investigation about Modern Deep Learning Strategies for Colon Carcinoma Grading
    Carcagni, Pierluigi
    Leo, Marco
    Signore, Luca
    Distante, Cosimo
    [J]. SENSORS, 2023, 23 (09)
  • [6] Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years
    Ghabra, Shadin
    Desale, Sameer
    Sugarbaker, Paul H.
    [J]. DISEASES OF THE COLON & RECTUM, 2023, 66 (10) : 1329 - 1338
  • [7] Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial
    Morton, Dion
    Seymour, Matthew
    Magill, Laura
    Handley, Kelly
    Glasbey, James
    Glimelius, Bengt
    Palmer, Andy
    Seligmann, Jenny
    Laurberg, Soren
    Murakami, Keigo
    West, Nick
    Quirke, Philip
    Gray, Richard
    FOxTROT Collaborative Grp
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08) : 1541 - +
  • [8] Nagtegaal ID, 2019, Digestive system tumour, V5th, P177
  • [9] Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis
    Nerad, Elias
    Lahaye, Max J.
    Maas, Monique
    Nelemans, Patty
    Bakers, Frans C. H.
    Beets, Geerard L.
    Beets-Tan, Regina G. H.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (05) : 984 - 995
  • [10] Localization of Colorectal Cancer Lesions in Contrast-Computed Tomography Images via a Deep Learning Approach
    Sahoo, Prasan Kumar
    Gupta, Pushpanjali
    Lai, Ying-Chieh
    Chiang, Sum-Fu
    You, Jeng-Fu
    Onthoni, Djeane Debora
    Chern, Yih-Jong
    [J]. BIOENGINEERING-BASEL, 2023, 10 (08):